G Model

BJP 86 1–6 ARTICLE IN PRESS

Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx

www.sbfgnosia.org.br/revista

Original Article

1 Anti-inflammatory and antinociceptive activities of non-alkaloids

2 fractions from flavum in vivo

a,1 a,1 a a a a,b,∗

3 Q1 Yuanbin Zhang , Zhiheng Shu , Lei Yin , Ling Ma , Xinfang Wang , Xueyan Fu

a

4 School of Pharmacy, Ningxia Medical University, Yinchuan, China

b

5 Ningxia Engineering and Technology Research Center for Modernization of Hui Medicine, Yinchuan, China

6

a r a b s t r a c t

t

i c

7 l e i n f o

8

9 Article history: Aconitum flavum Hand.-Mazz., , has been used for the treatment of rheumatism, trau-

10 Received 21 September 2014

matic injury in folk and clinical medicine, but the alkaloids has high toxicity. This study was designed

11 Accepted 28 November 2014

to investigate the acute toxicity, anti-inflammatory and antinociceptive activities of non-alkaloids frac-

12 Available online xxx

tions from A. flavum in rodents. The anti-inflammatory activity was evaluated by inflammatory models

13

of dimethylbenzene-induced ear vasodilatation and acetic acid-induced capillary permeability enhance-

14 Keywords:

ment test in mice and carrageenan-induced paw edema in rats whereas the antinociceptive activity was

15 Aconitum flavum

evaluated using acetic acid-induced writhes, hot plate test and formalin test in mice. The result showed

16 Anti-inflammatory activity

that the LD50 value of BtOH and EtOAc fractions could not be determined as no lethality was observed up

17 Antinociceptive activity

18 Non-alkaloids to 40 g/kg (p.o.) in mice. BtOH fraction significantly decreased the dimethylbenzene-induced ear vasodil-

atation, carrageenan-induced paw edema and acetic acid-induced capillary permeability. EtOAc fraction

only significantly attenuated paw edema and capillary permeability at the dose of 500 mg/kg. In antinoci-

ceptive test, BtOH and EtOAc fractions significantly reduced the writhing number evoked by acetic acid

injection and the licking time in both phases of the formalin test. Meanwhile BtOH and EtOAc fractions

had significant effect on hot plate test after 90 min. Our data indicate that the BtOH and EtOAc fractions of

NAF are no toxicity. BtOH and EtOAc fractions not only inhibit inflammatory and peripheral inflammatory

pain but also have central antinociceptive effect.

© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.

19 Introduction safety between therapeutic and toxic doses of these herbs. Lots of 32

researches showed that the effects and severe toxicity of Aconitum 33

20 The Aconitum consisting of over 300 are widely dis- are mainly attributed to alkaloids (Chan, 2012; Singhuber et al., 34

21 tributed in Asia, Europe and North America. Most of them grow 2009). Aconitine, mesaconitine, hypaconitine and other alkaloids 35

22 among high altitudes in the northern hemisphere. There are 200 have potent cardiotoxins and neurotoxins found in all parts of the 36

23 species grow in China such as Aconitum kusnezoffii Reichb., Aconi- Aconitum species, especially in the tubers and roots. Patients with 37

24 tum carmichaelithe Debx. and Aconitum flavum Hand. –Mazz. (Xiao, Aconitum poisoning often present with a combination of cardiovas- 38

25 2006). In traditional Chinese medicine, Aconitum have similar cular, neurological, gastrointestinal and other signs and symptoms. 39

26 pharmacological actions and are commonly applied for various The estimated lethal dose is 2 mg of aconitine, 5 mL of aconite 40

27 inflammatory diseases, such as rheumatic fever, painful joints, tincture (herbal medicinal wine) and 1 g of the raw aconite 41

28 gastroenteritis, diarrhea, edema, bronchial asthma and various (Chan, 2012; Qin et al., 2012). Facing this dangerous situation, the 42

29 tumors (Qin et al., 2012; Singhuber et al., 2009). However, with effects of non-alkaloids fraction are worth to explore, although the 43

30 the increasing popularity, Aconitum poisoning can occur in many alkaloids of Aconitum species were been seen as important compo- 44

31 parts of the world. Because the highly toxic and narrow margin of nents in disease treatment. Modern Chinese medicine theory has 45

been suggested that the chemical constituents of traditional Chi- 46

nese medicine are complex and many different kinds of chemical 47

compositions may treat the diseases in similar way by additive and 48

Q2 Corresponding author at: School of Pharmacy, Ningxia Medical University, synergy effect (Tu et al., 2012; Xu et al., 2014a). This theory urged 49

Yinchuan, China.

us to explore the effects of non-alkaloids fraction from Aconitum. 50

E-mail: [email protected] (X. Fu).

1 A. flavum Hand.-Mazz. from the family Ranunculaceae, is widely 51

These authors equally contributed to this manuscript; both should be considered

used in western China (Shanxi, Ningxia, , Inner Mongolia, 52

as first author.

http://dx.doi.org/10.1016/j.bjp.2014.11.013

0102-695X/© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013

G Model

BJP 86 1–6 ARTICLE IN PRESS

2 Y. Zhang et al. / Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx

53 Qinghai and ). It has been used for the treatment of rheuma- from Sigma Co., Ltd. The fractions of NAF were suspended in water 112

54 tism, traumatic injury and toothache in folk and clinical medicine with 0.5% (w/v) sodium carboxyl methyl cellulose (Na-CMC). 113

55 (Ting et al., 2008). To date, Chinese modern research about A. flavum

56 is mainly concentrated in pharmacological functions and quality Animal preparation 114

57 control of alkaloids and different processed products (the toxicity

58 of these products was reduced by decomposing the diester diter- The animals used in this study, including ICR mice (18–22 g; 115

59 pene alkaloids to the less toxic monoester diterpene alkaloids). License No.: SYXK (NING) 2011-0001) and Sprague-Dawley rats 116

60 However, there has been little research on anti-inflammatory and (180–220 g; License No.: SCXK (NING) 2012-0001) were purchased 117

61 antinociceptive activity of non-alkaloids fractions from A. flavum. from the Experimental Animal Center of Ningxia Medical Univer- 118

62 The aim of the present study is to evaluate the anti-inflammatory sity (Ningxia, China). They were maintained in standard laboratory 119

63 and analgesic effects of non-alkaloids fractions from A. flavum in cages, in moderate humidity (50 ± 5%), at constant temperature 120

±

64 standard rodent models of inflammation and pain. Additionally, we (22 1 C) in a 12-h light–dark cycle room. All animals had free 121

65 also studied acute oral toxicity of the non-alkaloids fractions. These access to food and water during the experimental period. The 122

66 studies will show a direction of finding low toxic compounds from experiment protocol was approved by the Ethics Committee of 123

67 Aconitum. Ningxia Medical University, Ningxia (Ethics approval: 2013-146). 124

68 Materials and methods Toxicity study 125

69 Herbal preparation and extraction The acute toxicity study of the non-alkaloids fractions was per- 126

formed according to OECD guidelines (2011). The EtOAc and BtOH 127

70 The roots of A. flavum Hand.-Mazz., Ranunculaceae, were pur- fractions was suspended in water with 0.5% (w/v) sodium carboxyl 128

71 chased from an Herbal Medicinal Materials Company of Mingde methyl cellulose (Na-CMC) in the dose of 120, 1200, 6000, 20,000 129

72 Pharmaceutical Co., Ltd (Ningxia, China). The Plant is growing in and 40,000 mg/kg body weight were orally administered to over- 130

73 Liupan mountain, Longde, Guyuan, Ningxia, China. The roots were night-fasted, healthy mice (n = 8) and the animals were observed 131

74 harvest in August to September. The plant sample was authen- continuously for 24 h for mortality. 132

75 ticated by Lin Dong at Pharmacognosy Department, College of

76 Pharmacy, Ningxia Medical University, and a voucher specimen Anti-inflammatory activity 133

77 was deposited in the same unit (Herbarium number: 20130924).

78 Sliced dried roots (3.7 kg) were extracted three times with 70% Dimethylbenzene (DMB)-induced ear vasodilatation assay 134

79 ethanol (mass ratio of solid to liquid was 1:10). The extract was The test was carried out according to the previously described 135

80 then combined and evaporated to dryness under reduced pres- method (Carlson et al., 1985). Mice of either sex were ran- 136

81 sure, which yielded 925 g crude extract. The crude extract was domly divided in eight groups (n = 8 per group). Control 137

82 dissolved in 20% (v/v) ethanol aqueous (2 L), and then diluted with group, indomethacin (10 mg/kg, positive group), EtOAc (500 138

83 a solution (5000 L) of hydrochloric acid 1% in 20% ethanol aqueous. and 250 mg/kg), BtOH (500 and 250 mg/kg) and H2O (500 and 139

84 The 001 × 7 strong acid polystyrene cation exchange resin (Anhui 250 mg/kg) were administered via oral gavage. 60 min after via gav- 140

85 Sanxing Resin Technology Co., Ltd., China) were selected for fur- age of test samples, the mice were topical applied 30 L DMB to 141

86 ther work. The sample solution was absorbed in column with a both inner and outer surface of right ear. Mice were sacrificed by 142

87 20 mL/min flow rate. Then column was washed with deionized cervical dislocation 30 min later then the ear biopsies of both ears 143

88 water until the effluent was colorless. The combined effluent was were obtained with a punch (a diameter of 8 mm) and weighed. 144

89 adjusted to pH 7 with a solution of sodium hydroxide and evap- Weight-increase-rate of the right ear over the left one indicated 145

90 orated using a rotary evaporator to give a non-alkaloids fraction the vasodilatation. 146

91 (NAF). The NAF was then suspended in distilled water and suc-

92 cessively partitioned with petroleum ether, ethyl acetate (EtOAc) Acetic acid-induced vascular permeability 147

93 and n-butanol (BtOH) to yield EtOAc (18.25 g) and BtOH (77.33 g) The acetic acid-induced increased vascular permeability in mice 148

94 fractions, as well as an H2O residue. was carried out using the reported technique (Whittle, 1964). 149

Briefly, grouping and administration were the same as mentioned 150

95 Estimation of the total phenolic, flavonoid and saponin content in ear vasodilatation assay. 60 min after via gavage, 10 mL/kg body 151

weight of 2% Evans blue in normal saline solution to the tail vein 152

96 The total amount of phenolic and flavonoid contents were then applied 20 mL/kg body weight of 0.6% (v/v) acetic acid imme- 153

97 determined in EtOAc and BtOH fractions using the Folin–Ciocalteu diately (i.p.). 20 min after the administration of acetic acid, the 154

98 colorimetric method and aluminum chloride colorimetric assay, mice were sacrificed by cervical dislocation. The peritoneal cavity 155

99 respectively. The percentage of total phenolic content expressed as was rinsed by 10 mL of saline. The washing solutions were col- 156

×

100 gallic acid equivalents for EtOAc and BtOH fractions were 15.08% lected in centrifuge tube and centrifuged at 1000 g for 5 min. 157

101 and 3.05%, respectively. But there have no flavonoid in NAF. In addi- The supernatant was measured at 590 nm by spectrometry and 158

102 tion, the saponins were measured by vanillin–perchloric acid assay. the absorbance of Evans blue in the exudates under 590 nm rep- 159

103 The saponin contents expressed as oleanolic acid equivalents were resented the capillary permeability. 160

104 9.37 and 3.83% respectively.

Carrageenan-induced paw edema 161

105 Drugs and chemicals The paw edema was induced according to Winter et al. (1962). 162

Animal of each sex were divided into seven groups of seven each. 163

106 The following drugs and chemicals were used: acetic acid, They were pretreated orally with the vehicle (0.5%, w/v sodium car- 164

107 dimethylbenzene and formaldehyde solution were purchased from boxyl methyl cellulose, control group), EtOAc (500 and 250 mg/kg), 165

108 Damao Chemical Company (Tianjin, China). Carrageenan (BR; no. BtOH (500 and 250 mg/kg), H2O (500 mg/kg) and indomethacin 166

109 Q1555) was from Shanghai Wanjiang Biological Technology Co., (10 mg/kg, p.o.). After 60 min, edema was induced with the injec- 167

110 Ltd. Indomethacin (no. A130602) was obtained from Shanxi Yun- tion of 0.1 mL of 3% (w/v) freshly prepared carrageenan suspension 168

111 peng Pharmaceutical Co., Ltd. Evans blue (no. E2129) was purchased in saline into the right hind paw of each rat. The inflammation was 169

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013

G Model

BJP 86 1–6 ARTICLE IN PRESS

Y. Zhang et al. / Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx 3

15

170 quantified by measuring the volume (mL) displaced by the paw

171 using a plethysmometer (Beijing Zhongshidichuang Science and

172 Technology Development Co., Ltd, model YLS-7C, China) at 0, 1, 2, 3,

173 4, 5 h after carrageenan injection. The edema volume was expressed

174 by the variation in volume between each time (1, 2, 3, 4 and 5 h) 10

175 and basal time (0 h). * * 176 Antinociceptive activity *

Edema (mg) 5

177 Acetic acid-induced writhing response

178 Mice were used according to the method previously reported

179 (Koster et al., 1959). The doses and the routes of administration

180 were provided in ear vasodilatation assay. 60 min after the via gav- 0

181 age, the responses to an intraperitoneal injection of acetic acid

182 solution, manifesting as a contraction of the abdominal muscles Control

183 stretching of hind limbs, were counted cumulatively after 5 min Indometacin O (500 mg/kg)O (250 mg/kg)

H 2 H 2

184 of stimulus over a period of 20 min. Nociception was induced by BtoH (500 mg/kg)BtoH (250 mg/kg)EtoAc (500 mg/kg)EtoAc (250 mg/kg)

185 intraperitoneal injection of 0.6% acetic acid solution at the dose of

Fig. 1. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500 and

186 20 mL/kg body weight.

250 mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on DMB-induced

ear vasodilatation. The result of ear edema represents mean ± SD (n = 8). Differences

187 Formalin test

between the groups were determined by an ANOVA followed by Dunnett’s test.

188 Formalin-induced nociception was induced in mice according *p < 0.05, **p < 0.01 when compared to the control group.

189 to a previously described procedure (Hunskaar et al., 1985). A vol-

190 ume of 20 ␮L of a 2.5% formalin solution in saline was injected

Anti-inflammatory effects on DMB-induced ear vasodilatation 226

191 intraplantarly (i.pl.) in the plantar surface of the right hind paw

192 to mice. After formalin injection, the mice were individually placed

Treatment with BtOH (500 and 250 mg/kg) 1 h before applied 227

193 in a glass cylinder of 22 cm diameter and were observed from 0

DMB in mice ears significantly (Fig. 1; p < 0.05) inhibited the edema 228

194 to 5 min (neurogenic pain response) and 15–30 min (inflamma-

formation when compared to the control group. Dose-dependent 229

195 tory pain response). The time spent licking the injected paw was

manner was observed at BtOH groups. BtOH group at the dose 230

196 recorded with a chronometer for both phases and considered as

of 500 mg/kg could remarkably decrease the vasodilatation with 231

197 indicative of nociception. The animals were pretreated with oral

inhibition rate over 50%. 232

198 doses of vehicle, indomethacin, EtOAc (500 and 250 mg/kg), BtOH

199 (500 and 250 mg/kg) and H2O (500 and 250 mg/kg) 60 min before

Anti-inflammatory effects on acetic acid-induced vascular 233

200 formalin administration.

permeability enhancement 234

201 Hot plate test

Fig. 2 showed acid-induced vascular permeability enhancement 235

202 Mice were subjected to the hot plate test (MacDonald et al.,

was significantly (p < 0.05, compared to control group) inhibited 236

203 1946; Sahley and Berntson, 1979). A glass cylinder was placed on a

in mice pretreated orally with BtOH fraction and EtOAc fraction 237

204 hot-plate with adjustable temperature. The temperature of the hot-

◦ (500 mg/kg, p.o.), with an inhibition of 32.13 and 27.30%, respec- 238

205 plate was then regulated to 55 ± 1 C. The female mice with baseline

tively. The standard drug reference indomethacin resulted in a 239

206 latencies of more than 20 s were eliminated from the study and the

significant reduction (39.46%) of the control number. 240

207 cut-off time of 40 s was fixed to avoid damage to the paws. Each

208 mouse was placed in the glass on the hot-plate in order to obtain

3

209 the animal’s response to heat-induced nociceptive pain stimulus

210 (linking of the hindpaws, jumping or shaking). The reaction times

211 obtained at 0, 30, 60, 90 and 120 min prior to via gavage of vehicle

212 and drugs. 2

213 Statistical analysis ** *

**

214 The results were analyzed using a statistical program SPSS

215 Statistics, version 17.0. One-way ANOVA followed by Dunnett’s 1

216 test was used for determining the statistically significant differ-

Absorbance of evance blue Absorbance of evance

217 ences between the values of various experimental groups. Data are

218 expressed as means ± SD and p < 0.05 was considered statistically 219 significant. 0

220 Results Control

Indometacin O (500 mg/kg)O (250 mg/kg)

2 2

221 Acute toxicity studies H H

BtoH (500 mg/kg)BtoH (250 mg/kg)EtoAc (500 mg/kg)EtoAc (250 mg/kg)

222 The EtOAc and BtOH fractions from NAF at various dose levels Fig. 2. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500 and

250 mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on the capillary

223 did not show any mortality, any morbid symptoms or deleterious

permeability under acetic acid challenge. The absorbance of Evans Blue in the leak-

224 effects even at the highest dose (40 g/kg, orally). The LD50 value by

age under 590 nm represented indicated the capillary permeability. Date represents

225 oral route could not be determined as no lethality was observed up

mean ± SD (n = 8). Differences between the groups were determined by an ANOVA

to 40 g/kg in mice. followed by Dunnett’s test. *p < 0.05, **p < 0.01 when compared to the control group.

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013

G Model

BJP 86 1–6 ARTICLE IN PRESS

4 Y. Zhang et al. / Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx Control Indometacin

BtoH (500 mg/kg) BtoH (250 mg/kg)

EtoAc (500 mg/kg) EtoAc (250 mg/kg)

H2O (500 mg/kg)

0.55

0.50

0.45

0.40 * 0.35 * 0.30 * * * 0.25 * * * * * * Edema volume (mL) 0.20 *

0.15 * * 0.10 * * ** * * 0.05 * 0.00

1 2 3 4 5

Time (h)

Fig. 3. Anti-inflammatory activity of BtOH (500 and 250 mg/kg), EtOAc (500 and 250 mg/kg), H2O (500 mg/kg) or indomethacin (10 mg/kg) in carrageenan induced hind paw

edema. Results were obtained by oral administration of NAF fractions, indomethacin and vehicle. Each value represents the mean ± SD of results from seven rats. Differences

from the control group were determined by ANOVA followed by Dunnett’s test. *p < 0.01.

241 Anti-inflammatory effects on carrageenan-induced paw edema 60

242 Treatment of animals with BtOH fractions (500, 250 mg/kg, p.o.)

243 and EtOAc fraction (500 mg/kg) 1 h before injection of carrageenan *

244 significantly (Fig. 3; p < 0.01) inhibited the edema formation at 40

245 1–5 h when compared to control group. But EtOAc fraction at **

246 dose of 250 mg/kg only significantly decreased the edema at 1 h. **

247 Indomethacin (10 mg/kg, p.o.) also produced a significant inhibi- **

248 tion of the carrageenan-induced paw edema at 1, 2, 3, 4 and 5 h 20

Number of writhes

249 when compared to control (Fig. 3; p < 0.01).

250 Anti-nociceptive activity on acetic acid-induced writhes

0

251 In the acetic acid-induced writhing mice (shown in Fig. 4), EtOAc

Control

252 fractions (250–500 mg/kg, p.o.) evoked a dose-dependent inhibi- Indometacin

O (500 mg/kg)O (250 mg/kg)

253 tion, the inhibitory percentage of 44.67% and 28.11%, respectively. H 2 H 2

BtoH (500 mg/kg)BtoH (250 mg/kg)EtoAc (500 mg/kg)EtoAc (250 mg/kg)

254 All doses of EtOAc fractions significantly (p < 0.01 and p < 0.05)

255 inhibited the frequency induced abdominal constrictions by acetic

Fig. 4. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500

256 acid when compared to the control group. Treatment with BtOH and 250 mg/kg), H2O (500 and 250 mg/kg) or indomethacin (10 mg/kg) on acetic

acid-induced writhing in mice. Each value represents mean ± SD (n = 8). *p < 0.05,

257 fraction at dose of 500 mg/kg also showed antinociceptive effect in

**p < 0.01 when compared to the control group.

258 comparison with the control (p < 0.01).

259 Anti-nociceptive activity on formalin test

p.o.) only significantly reduced the inflammatory (75.8%) phase of 269

formalin-induced nociception. 270

260 Fig. 5 shows that both first (neurogenic pain) and second

261 (inflammatory pain) phases of formalin-induced nociception were

262 significantly (p < 0.01, compared to control group) inhibited in mice

Anti-nociceptive activity on hot plate test 271

263 pretreated orally with BtOH fractions (500, 250 mg/kg, p.o.) and

264 EtOAc fraction (500 mg/kg). EtOAC fraction at dose of 250 mg/kg

In the hot plate test, the results presented in Fig. 6 showed 272

265 only significantly (p < 0.05) inhibited the nociception at second

that significant (p < 0.01 and p < 0.05) antinociceptive effect in BtOH 273

266 phase compared to control group. The inhibitions were 50.8 and

fraction and EtOAc fraction groups (500 mg/kg) at 90 and 120 min 274

267 80.3% in BtOH group at the dose of 500 mg/kg, for the first and

after administration when compared to control groups. 275

268 second phases, respectively. In contrast, indomethacin (10 mg/kg,

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013

G Model

BJP 86 1–6 ARTICLE IN PRESS

Y. Zhang et al. / Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx 5

285

150 1 st phase 2 st phase high molecular weight components such as ions of alkaloids (Yang

and Kong, 2009). The ions of alkaloids were retained in chromato- 286

graphic column, but the non-alkaloids fractions could be washed 287

using deionized water. In our study, no deaths or serious clinical 288

signs in both EtOAc and BtOH fractions at the highest dose of 40 g/kg 289

100 #

(this dose is much higher than the dose of treatment) in acute tox- 290

icity study. Although the evidence of risk in longer use is unknown, 291

## ** ##

but the acute toxic results sufficiently support the fact that BtOH 292

**

** and EtOAc fractions of NAF have no toxicity. 293

Licking time (s) 50

Xylene-induced ear edema in mice is a preliminary and 294

simple acute inflammation model for evaluating potential anti- 295

## ##

inflammatory agents (Cheng et al., 2005). Ear edema may involve 296

inflammatory mediators such as histamine, kinin, fibrinolysin, 297

0 phospholipase A2 and PLA2. These mediators induce edema by pro- 298

moting vasodilation and increasing vascular permeability (Li et al., 299

Control

2011; Xu et al., 2014b). The BtOH fraction of NAF was able to reduce 300

Indometacin

O (500 mg/kg)O (250 mg/kg) inflammation in this model and acetic acid-induced vascular per- 301 2 2

BtoH (500 mg/kg)BtoH (250 mg/kg) H H

EtoAc (500 mg/kg)EtoAc (250 mg/kg) meability enhancement model. These results suggest that BtOH 302

fraction may interfere with the actions of inflammatory mediators 303

Fig. 5. The antinociceptive action of BtOH (500 and 250 mg/kg), EtOAc (500 and

and produce the anti-inflammatory effect. Carrageenan-induced 304

250 mg/kg) and H2O (500 and 250 mg/kg) on both first (0–5 min) and second

paw edema is a largely used test for screening both steroidal 305

(15–30 min) phases of the formalin-induced nociception. Each value represents

mean ± SD (n = 8). *p < 0.05, **p < 0.01 by an ANOVA followed by Dunnett’s test com- anti-inflammatory drugs and NSAID. The inflammatory response 306

# ##

pared to control group at first phase. p < 0.05, p < 0.01 by an ANOVA followed by involves three phases through sequential release of several medi- 307

Dunnett’s test compared to control group at second phase.

ators. The early phase (the first 90 min) involves the release of 308

histamine and serotonin; the second phase (90–150 min) is medi- 309

276 Discussion ated by kinin and the third phase (after 180 min) is mediated by 310

prostaglandin (Di Rosa et al., 1971). The results from this study 311

312

277 The toxicity of alkaloids from A. flavum Hand.-Mazz, Ranuncu- suggest that the BtOH and EtOAc fractions of NAF possibly act by

313

278 laceae, has made us worried, so to obtain nature products with inhibiting the release or action of histamine, serotonin and kinin

314

279 favorable effects and low toxicity from A. flavum become a mean- and prostaglandin of the edema development.

315

280 ingful research direction. In order to realize this objective, we The analgesic activity of NAF fractions in this study was investi-

316

281 studied the non-alkaloids fractions from this herb. In our study, gated using the abdominal writhing, formalin and hot plate tests in

317

282 001 × 7 strong acid polystyrene cation exchange resin which is mice. The writhing model induced by acetic acid in mice was com-

318

283 a low cross-linking resin and has porous structure was selected monly considered as classical peripheral inflammatory pain animal

319

284 for preparing NAF. This resin may be beneficial to adsorb alkaline model for evaluation of analgestic or anti-inflammatory drugs

Control BtoH (250 mg/kg)

BtoH (500 mg/kg) EtoAc (250 mg/kg) EtoAc (500 mg/kg) H2O (250 mg/kg)

H2O (500 mg/kg)

30 * ** * **

25

20

15 Latency time (s)

10

5 0 30 60 90 120

Time (min)

Fig. 6. Effects of oral pretreatment with BtOH (500 and 250 mg/kg), EtOAc (500 and 250 mg/kg) and H2O (500 and 250 mg/kg) on hot-plate test in mice. Date represents

mean ± SD (n = 8). Differences between the groups were determined by an ANOVA followed by Dunnett’s test. *p < 0.05, **p < 0.01 when compared to the control group.

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013

G Model

BJP 86 1–6 ARTICLE IN PRESS

6 Y. Zhang et al. / Revista Brasileira de Farmacognosia xxx (2015) xxx–xxx

320 (Negus et al., 2006). The peripheral analgesic is due to the liberation and Technology Project of Ningxia Province of China (Project No. 377

321 of several inflammatory mediators such as bradykinin, substance 170). 378

322 P, prostaglandins and cyclo-oxygenases, lipoxygenases, as well as

323 some cytokines such as IL-1␤, TNF-␣ and IL-8 (Ikeda et al., 2001; References 379

324 Ribeiro and Poole, 2000). The hot plate test has been found suitable

Carlson, R.P., O’Neill-Davis, L., Chang, J., Lewis, A.J., 1985. Modulation of mouse ear 380

325 to evaluate centrally antinociceptive (Hiruma-Lima et al., 2000). In

edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic 381

326 order to further clarify the antinociceptive effect of NAF fractions,

agents. Agents Actions 17, 197–204. 382

327 the formalin test was carried out. This model is validly used in anal- Chan, T.Y., 2012. Aconitum alkaloid content and the high toxicity of aconite tincture. 383

Forensic Sci. Int. 222, 1–3. 384

328 gesia research (Tjølsen et al., 1992), it involves two phases (Zakaria

Cheng, W., Li, J., You, T., Hu, C., 2005. Anti-inflammatory and immunomodulatory 385

329 et al., 2008). The first phase (0–5 min) is characterized by neuro-

activities of the extracts from the inflorescence of Chrysanthemum indicum Linne. 386

330

genic pain caused by a direct stimulation of nociceptors. Substance J. Ethnopharmacol. 101, 334–337. 387

388

331 P and bradykinin are thought to participate in this phase (Hunskaar Di Rosa, M., Giroud, J.P., Willoughby, D.A., 1971. Studies on the mediators of the

acute inflammatory response induced in rats in different sites by carrageenan 389

332 and Hole, 1987). The second phase (15–30 min) is characterized by

and turpentine. J. Pathol. 104, 15–29. 390

333 inflammatory pain, a process in which several inflammatory medi-

Hiruma-Lima, C.A., Gracioso, J.S., Bighetti, E.J.B., 2000. The juice of the fresh leaves 391

334 ators are believed to be involved, including histamine, serotonin, of Boerhaavia diffusa L. (Nyctaginaceae) markedly reduces pain in mice. J. 392

Ethnopharmacol. 71, 267–274. 393

335 prostaglandins and bradykinin (Tjølsen et al., 1992). In general, cen-

Hunskaar, S., Berge, O.G., Hole, K., 1985. Formalin test in mice, a useful technique for 394

336 trally acting drugs inhibit both phases equally, while peripherally

evaluating mild analgesics. J. Neurosci. Methods 14, 69–76. 395

337 acting drugs inhibit the second phase (Xu et al., 2014b). As pre- Hunskaar, S., Hole, K., 1987. The formalin test in mice: dissociation between inflam- 396

matory and non-inflammatory pain. Pain 30, 103–114. 397

338 sented in Fig. 5, the BtOH and EtOAc fractions of NAF suppressed

Ikeda, Y., Ueno, A., Naraba, H., Oh-ishi, S., 2001. Involvement of vanilloid receptor 398

339 the pain in two phases. The results obtained from the formalin test

VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci. 399

340 were therefore in good agreement with the results from the hot- 69, 2911–2919. 400

Koster, R., Anderson, M., Debeer, E.J.M., 1959. Acetic acid for analgesic screening. 401

341 plate test and writhing test, thereby indicating that BtOH and EtOAc

Fed. Proc. 18, 412–418. 402

342 fractions of NAF had central and peripheral analgesic property.

Li, Y.C., Xian, Y.F., Ip, S.P., Su, Z.R., Su, J.Y., He, J.J., Xie, Q.F., Lai, X.P., Lin, Z.X., 2011. Anti- 403

343 These results obtained from inflammation and pain animal model inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in 404

animal models. Fitoterapia 82, 1295–1301. 405

344 confirm that BtOH and EtOAc fractions could inhibition of the pro-

MacDonald, A.D., Woolfe, G., Bergel, F., Morrison, A.L., Rinderknecht, H., 1946. Anal- 406

345 duction of inflammatory mediators such as histamine, serotonin,

gesic action of pethidne derivatives and related compounds. Br. J. Pharmacol. 1, 407

346 prostaglandins and bradykinin. 4–14. 408

409

347 Although this research obtained meaningful results, it still Negus, S.S., Vanderah, T.W., Brandt, M.R., Bilsky, E.J., Becerra, L., Borsook, D., 2006.

Preclinical assessment of candidate analgesic drugs: recent advances and future 410

348 existed many problems worth us thinking and improving. The

challenges. J. Pharmacol. Exp. Ther. 319, 507–514. 411

349 chemical compositions of BtOH and EtOAc fractions are not very

Qin, Y., Wang, J.B., Zhao, Y.L., Shan, L.M., Li, B.C., Fang, F., Jin, C., Xiao, X.H., 2012. 412

350 clear. Together with previous studies, the constituents of Aconitum Establishment of a bioassay for the toxicity evaluation and quality control of 413

Aconitum herbs. J. Hazard. Mater. 199–200, 350–357. 414

351 also include flavonoids, phenolic acids and saponins besides alka-

Ribeiro, R.A., Vale, M.L., Thomazzi, S.M., Paschoalato, A.B., Poole, S., Ferreira, S.H., 415

352 loids (Shrestha et al., 2006; Wuljitegus et al., 2008). The flavonoids,

Cunha, F.Q., 2000. Involvement of resident macrophages and mast cells in the 416

353Q3 saponins and phenolic acids in those two NAF fractions were ana- writhing nociceptive response induced by zymosan and acetic acid in mice. Eur. 417

J. Pharmacol. 389, 111–118. 418

354 lyzed by ultraviolet spectrophotometry in our study. No flavonoids

Sahley, T.L., Berntson, G.G., 1979. Antinociceptive effects of central and systemic 419

355 were identified in those two fractions. However the phenolic acids

administration of nicotine in the rat. Psychopharmacology (Berl.) 65, 279–283. 420

356 and saponins gave a 15.08 and 9.73 percent in EtOAc fractions. Shrestha, B.B., Dall’Acqua, S., Gewali, M.B., Jha, P.K., Innocenti, G., 2006. New 421

flavonoid glycosides from Aconitum naviculare (Bruhl) Stapf, a medicinal herb 422

357 At the same time, the phenolic acids and saponins percentage of

from the trans-Himalayan region of Nepal. Carbohydr. Res. 341, 2161–2165. 423

358 BtOH fraction were 3.05% and 3.83%. With reference to the results

Singhuber, J., Zhu, M., Prinz, S., Kopp, B., 2009. Aconitum in traditional Chinese 424

359 that EtOAc and BtOH fractions of NAF have anti-inflammatory and medicine: a valuable drug or an unpredictable risk? J. Ethnopharmacol. 126, 425

18–30. 426

360 antinociceptive effects at high dose, we can speculate that the

Ting, W., Donghai, X., Haiyan, X., Ping, S., 2008. A review of Aconitum flavum Hand- 427

361 anti-inflammatory and antinociceptive effects of EtOAc and BtOH

Mazz. Lishizhen Med. Materia Medica Res. 19, 2162–2163. 428

362

fractions may be attributed to chemical components with low con- Tjølsen, A., Berge, O.-G., Hunskaar, S., Rosland, J.H., Hole, K., 1992. The formalin test: 429

430

363 centration, such as phenolic acids and saponins. an evaluation of the method. Pain 51, 5–17.

Tu, P., Shi, S., Jiang, Y., 2012. Strategies and approaches on exploring material basis 431

of Chinese materia medica. Chin. Trad. Herbal Drugs 43, 209–215. 432

364

Authors’ contributions Whittle, B.A., 1964. The use of changes in capillary permeability in mice to distin- 433

guish between narcotic and nonnarcotic analgesics. Br. J. Pharmacol. Chemother. 434

22, 246–253. 435

365 YZ, ZS and YL contributed in collecting plant samples and

Winter, C.A., Risley, E.A., Nuss, G.W., 1962. Carrageenan-induced oedema in hind 436

366 running the laboratory work. LM contributed to estimation of

paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 437

367 the chemical composition. LY contributed in analysis of the data. 111, 544–547. 438

Wuljitegus, Gao, Y., Huang, D., Su, Y., Liu, Z., 2008. Progress in studies on chemical 439

368 YZ wrote manuscript. XW contributed to critical reading of the

constituents of the Aconitum. J. Med. Pharm. Chin. Minorities 4, 68–72. 440

369 manuscript. XF designed the study, supervised the laboratory

Xiao, P.-G., 2006. A pharmacophylogenetic study of Aconitum L. (Ranunculaceae) 441

370 work and contributed to the critical reading of the manuscript. from China. Acta Phytotaxon. Sin. 44, 1–46. 442

Xu, F., Yang, D., Shang, M., Wang, X., Cai, S., 2014a. Effective forms, additive effect, 443

371 All the authors have read the final manuscript and approved

and toxicities scattering effect of pharmacodynamic substances of Traditional 444

372 submission.

Chinese Medicines (TCMs). Some reflections evoked by the study on TCM 445

Metabolic Disposition. World Sci. Technol.: Mod. Tradit. Chin. Med. Mater. Med. 446

16, 688–703. 447

373 Conflict of interest

Xu, Q., Wang, Y., Guo, S., Shen, Z., Wang, Y., Yang, L., 2014b. Anti-inflammatory 448

and analgesic activity of aqueous extract of Flos populi. J. Ethnopharmacol. 152, 449

374 The authors have declared that there is no conflict of interest. 540–545. 450

Yang, Y., Kong, D., 2009. The Extraction and Separation Technology of Traditional 451

Chinese Medicine. Chemical Industry Press, Beijing, pp. 249–256. 452

375 Acknowledgements

Zakaria, Z.A., Ghani, Z.D., Nor, R.N., Gopalan, H.K., Sulaiman, M.R., Jais, A.M., 453

Somchit, M.N., Kader, A.A., Ripin, J., 2008. Antinociceptive, anti-inflammatory, 454

and antipyretic properties of an aqueous extract of Dicranopteris linearis leaves 455

376Q4 This work was supported by grants form the National Nature

in experimental animal models. J. Nat. Med. 62, 179–187. 456

Science Foundation of China (Project No. 81102892) and Science

Please cite this article in press as: Zhang, Y., et al. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from

Aconitum flavum in vivo. Revista Brasileira de Farmacognosia (2015), http://dx.doi.org/10.1016/j.bjp.2014.11.013